Total Payments
$63,849
2024 Payments
$12,187
Companies
22
Transactions
191
Medicare Patients
817
Medicare Billing
$72,484
Payment Breakdown by Category
Consulting$21,541 (33.7%)
Other$16,376 (25.6%)
Travel$14,141 (22.1%)
Food & Beverage$10,493 (16.4%)
Education$1,298 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,541 | 6 | 33.7% |
| Honoraria | $16,376 | 7 | 25.6% |
| Travel and Lodging | $14,141 | 25 | 22.1% |
| Food and Beverage | $10,493 | 142 | 16.4% |
| Education | $1,298 | 11 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $24,585 | 63 | $0 (2024) |
| GlaxoSmithKline, LLC. | $8,328 | 25 | $0 (2024) |
| Blueprint Medicines Corporation | $7,785 | 15 | $0 (2024) |
| Eli Lilly and Company | $7,390 | 13 | $0 (2024) |
| Genentech USA, Inc. | $6,040 | 22 | $0 (2024) |
| Pharming Healthcare, Inc. | $3,609 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,375 | 1 | $0 (2020) |
| GENZYME CORPORATION | $1,335 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,225 | 12 | $0 (2024) |
| Grifols USA, LLC | $430.98 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,187 | 38 | Eli Lilly and Company ($7,390) |
| 2023 | $11,014 | 41 | CSL Behring ($5,430) |
| 2022 | $3,138 | 19 | Blueprint Medicines Corporation ($2,226) |
| 2021 | $14.40 | 1 | Genentech USA, Inc. ($14.40) |
| 2020 | $11,500 | 12 | GlaxoSmithKline, LLC. ($5,945) |
| 2019 | $3,129 | 27 | GlaxoSmithKline, LLC. ($1,605) |
| 2018 | $7,866 | 29 | CSL Behring ($6,857) |
| 2017 | $15,000 | 24 | CSL Behring ($10,562) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $127.11 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $120.45 | General |
| Category: Immunology | ||||||
| 10/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $110.32 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.97 | General |
| 10/25/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $122.54 | General |
| 08/01/2024 | Eli Lilly and Company | — | Travel and Lodging | Cash or cash equivalent | $499.82 | General |
| 08/01/2024 | Eli Lilly and Company | — | Travel and Lodging | Cash or cash equivalent | $118.20 | General |
| 08/01/2024 | Eli Lilly and Company | — | Travel and Lodging | Cash or cash equivalent | $75.00 | General |
| 08/01/2024 | Eli Lilly and Company | — | Food and Beverage | Cash or cash equivalent | $41.00 | General |
| 08/01/2024 | Eli Lilly and Company | — | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| 08/01/2024 | Eli Lilly and Company | — | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| 08/01/2024 | Eli Lilly and Company | — | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| 07/31/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $164.00 | General |
| Category: BIOLOGIC | ||||||
| 07/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $120.58 | General |
| Category: Immunology | ||||||
| 07/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $110.07 | General |
| Category: Immunology | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $113.59 | General |
| 06/03/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $92.51 | General |
| Category: Immunology and Neurology | ||||||
| 05/23/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $121.52 | General |
| Category: Immunology | ||||||
| 05/22/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $6,300.00 | General |
| 05/17/2024 | Eli Lilly and Company | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $97.81 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Eli Lilly and Company | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $62.79 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Eli Lilly and Company | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $61.60 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Eli Lilly and Company | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $46.19 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Eli Lilly and Company | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Immunology | ||||||
| 04/24/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $89.72 | General |
| Category: Immunology and Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 182 | 578 | $53,408 | $16,714 |
| 2022 | 6 | 208 | 489 | $56,577 | $17,442 |
| 2021 | 6 | 239 | 661 | $69,416 | $20,901 |
| 2020 | 7 | 188 | 224 | $57,553 | $17,426 |
Total Patients
817
Total Services
1,952
Medicare Billing
$72,484
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 104 | 152 | $31,194 | $10,927 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 29 | 29 | $9,026 | $2,876 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 17 | $4,748 | $1,885 | 39.7% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Facility | 2023 | 15 | 360 | $7,200 | $899.72 | 12.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 20 | 20 | $1,240 | $126.56 | 10.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 93 | 134 | $27,334 | $9,510 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 49 | 49 | $15,370 | $4,753 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 14 | 18 | $4,960 | $1,708 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 14 | 15 | $2,067 | $795.49 | 38.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Facility | 2022 | 12 | 240 | $4,800 | $436.79 | 9.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 26 | 33 | $2,046 | $238.27 | 11.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 93 | 124 | $25,692 | $8,864 | 34.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 60 | 60 | $19,560 | $5,773 | 29.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 24 | 28 | $7,872 | $2,858 | 36.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 36 | 41 | $5,500 | $2,111 | 38.4% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Facility | 2021 | 12 | 392 | $9,800 | $1,184 | 12.1% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 14 | 16 | $992.00 | $110.85 | 11.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 53 | 71 | $19,707 | $5,883 | 29.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 52 | 65 | $13,712 | $3,947 | 28.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 24 | 24 | $9,732 | $3,280 | 33.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $5,800 | $1,961 | 33.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 14 | 14 | $4,564 | $1,238 | 27.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 19 | 24 | $3,170 | $979.19 | 30.9% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2020 | 14 | 14 | $868.00 | $137.95 | 15.9% |
About Dr. Andrej Petrov, MD
Dr. Andrej Petrov, MD is a Specialist healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538134069.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrej Petrov, MD has received a total of $63,849 in payments from pharmaceutical and medical device companies, with $12,187 received in 2024. These payments were reported across 191 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($21,541).
As a Medicare-enrolled provider, Petrov has provided services to 817 Medicare beneficiaries, totaling 1,952 services with total Medicare billing of $72,484. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Pittsburgh, PA
- Active Since 02/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1538134069
Products in Payments
- Haegarda (Biological) $9,697
- NUCALA (Biological) $7,986
- Xolair (Biological) $5,909
- RUCONEST (Biological) $3,609
- AYVAKIT (Drug) $3,197
- TAKHZYRO (Biological) $1,375
- DUPIXENT (Biological) $1,240
- Hizentra (Biological) $590.31
- FASENRA (Drug) $505.05
- Xembify (Biological) $430.98
- EBGLYSS (Drug) $294.05
- TRELEGY ELLIPTA (Drug) $255.45
- TEZSPIRE (Biological) $210.13
- ACTIMMUNE (Drug) $134.61
- FASENRA (Biological) $129.94
- NIOX VERO DEVICE (Device) $128.91
- Xhance (Drug) $127.11
- Gammaplex (Drug) $125.23
- CINRYZE (Drug) $125.00
- CINQAIR (Drug) $115.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Pittsburgh
Dr. Lawrence Crossett, Md, MD
Specialist — Payments: $5.3M
Specialist $5.3M
Dr. James Bradley, Md, MD
Specialist — Payments: $5.0M
Specialist $5.0M
Darrell Triulzi
Specialist — Payments: $3.3M
Specialist $3.3M
Dr. Mark Yazer, Md, MD
Specialist — Payments: $2.4M
Specialist $2.4M
Lirong Qu
Specialist — Payments: $2.4M
Specialist $2.4M
Dr. Miguel Regueiro, Md, MD
Specialist — Payments: $1.4M
Specialist $1.4M